Cholecystokinin (CCK) and schizophrenia: the selective CCKB antagonist LY262691 decreases midbrain dopamine unit activity - Concepedia

Concepedia

Publication | Closed Access

Cholecystokinin (CCK) and schizophrenia: the selective CCKB antagonist LY262691 decreases midbrain dopamine unit activity

53

Citations

9

References

1991

Year

Kurt Rasmussen, Marsha E. Stockton, Janet F. Czachura, J. Jeffry Howbert

European Journal of Pharmacology

PsychiatryMedicineDopamine Unit ActivityNeurotransmitterPsychopharmacologySchizophreniaNeuropharmacologyNeuroscienceBiological PsychiatryDopaminePharmacologySocial Sciences

References

	Year	Citations

Page 1